Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,835 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.
Akiyama Y, Morioka S, Tsuzuki S, Yoshikawa T, Yamato M, Nakamura H, Shimojima M, Takakusaki M, Saito S, Takahashi K, Sanada M, Komatsubara M, Takebuchi K, Yamaguchi E, Suzuki T, Shimokawa K, Kurosu T, Kawahara M, Oishi K, Ebihara H, Ohmagari N. Akiyama Y, et al. Among authors: saito s. J Infect Chemother. 2024 Jun;30(6):488-493. doi: 10.1016/j.jiac.2023.11.025. Epub 2023 Nov 30. J Infect Chemother. 2024. PMID: 38042298 Free article. Clinical Trial.
Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study.
Morioka S, Nikaido M, Tsuzuki S, Kutsuna S, Saito S, Hayakawa K, Sugiyama M, Ohmagari N. Morioka S, et al. Among authors: saito s. J Infect Chemother. 2024 Aug;30(8):734-740. doi: 10.1016/j.jiac.2024.02.009. Epub 2024 Feb 11. J Infect Chemother. 2024. Retraction in: J Infect Chemother. 2025 Feb;31(2):102561. doi: 10.1016/j.jiac.2024.11.011 PMID: 38350510 Free article. Retracted.
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot study.
Hayakawa K, Saito S, Miyoshi-Akiyama T, Fukui Y, Takemoto N, Hashimoto T, Inagaki T, Hirose K, Kobayashi K, Koizumi R, Endo M, Komatsubara M, Nomoto H, Inada M, Ide S, Kamegai K, Ashida S, Nagata N, Kato H, Ohmagari N. Hayakawa K, et al. Among authors: saito s. J Infect Chemother. 2024 Dec;30(12):1274-1279. doi: 10.1016/j.jiac.2024.06.007. Epub 2024 Jun 13. J Infect Chemother. 2024. PMID: 38879077
Retraction notice to "Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study" [J Infect Chemother 30 (2024) 734-740].
Morioka S, Nikaido M, Tsuzuki S, Kutsuna S, Saito S, Hayakawa K, Sugiyama M, Ohmagari N. Morioka S, et al. Among authors: saito s. J Infect Chemother. 2025 Feb;31(2):102561. doi: 10.1016/j.jiac.2024.11.011. Epub 2024 Nov 16. J Infect Chemother. 2025. PMID: 39551259 No abstract available.
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Iwasaki H, Yano R, Suzuki T, Saito S, Okumura N, Sugiura W, Ohmagari N, Ujiie M. Tomita N, et al. Among authors: saito s. Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219. doi: 10.1080/21645515.2023.2242219. Hum Vaccin Immunother. 2023. PMID: 37559375 Free PMC article. Clinical Trial.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Suzuki T, Asai Y, Takahashi K, Sanada M, Shimanishi Y, Terada M, Sato L, Inada M, Yamada G, Akiyama Y, Oshiro Y, Shiratori K, Togano T, Takamatsu Y, Kenji M, Matsunaga A, Ishizaka Y, Nomoto H, Iwamoto N, Saito S, Kutsuna S, Morioka S, Ohmagari N. Suzuki T, et al. Among authors: saito s. Heliyon. 2023 Sep 29;9(10):e20568. doi: 10.1016/j.heliyon.2023.e20568. eCollection 2023 Oct. Heliyon. 2023. PMID: 37842585 Free PMC article.
7,835 results